Skip to main content
Top

Journal of Radiation Oncology

Issue 3/2018

Content (11 Articles)

Review

Re-irradiation in gynecological cancers, present experiences and future hopes

Susovan Banerjee, Shikha Goyal, Tejinder Kataria, Deepak Gupta, Kanhu Charan Patro, Abhidha Malik, Shyam Singh Bisht, Ashu Abhishek

Original Research

Factors predictive of neoadjuvant versus adjuvant chemoradiotherapy in locally advanced rectal cancer and the impact on overall survival

Alex Coffman, Dustin Boothe, Jonathan Frandsen, Molly Gross, Thomas Bartley Pickron, Courtney L. Scaife, Shane Lloyd

Original Research

A comprehensive analysis of clinical trials including both immunotherapy and radiation therapy

Dustin Boothe, Joseph W. Clyde, Michael Christensen, Shiven B. Patel, Shane Lloyd

Original Research

Tolerability of sequential immune therapy and palliative radiotherapy to the cervical and thoracic spine

W. Tristram Arscott, Abigail Doucette, Pallavi Kumar, John P. Plastaras, Amit Maity, Joshua Jones

Original Research

Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey

Erik Scott Blomain, Hyun Kim, Shivank Garg, Deepak Bhamidipati, Jenny Guo, Ingrid Kalchman, John McAna, Wenyin Shi

Original Research

Reducing radiation dermatitis during ongoing radiation therapy: an innovative film-forming wound dressing

Amparo Quilis, Jaime Martín, Concepción Rodríguez, Purificación Sánchez, Juan Luis Ribes

Study Protocol

A phase II trial to determine the cosmetic outcomes and toxicity of 27 Gy in five-fraction accelerated partial breast irradiation: the ACCEL trial

Petra Grendarova, Sarah Quirk, Michael Roumeliotis, Mark Lesiuk, Tammy Austin, Katelyn Bignell, Hongwei Liu, Peter Craighead, Jane Wilson, Tien Phan, Ivo A. Olivotto

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine